202 related articles for article (PubMed ID: 27732968)
1. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
[TBL] [Abstract][Full Text] [Related]
2. The impact of SBF2 on taxane-induced peripheral neuropathy.
Cunningham GM; Shen F; Wu X; Cantor EL; Gardner L; Philips S; Jiang G; Bales CL; Tan Z; Liu Y; Wan J; Fehrenbacher JC; Schneider BP
PLoS Genet; 2022 Jan; 18(1):e1009968. PubMed ID: 34986146
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.
Shen F; Jiang G; Philips S; Gardner L; Xue G; Cantor E; Ly RC; Osei W; Wu X; Dang C; Northfelt D; Skaar T; Miller KD; Sledge GW; Schneider BP
Clin Cancer Res; 2023 Jul; 29(13):2494-2500. PubMed ID: 37126018
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW
Clin Cancer Res; 2015 Nov; 21(22):5082-5091. PubMed ID: 26138065
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
Sucheston-Campbell LE; Clay-Gilmour AI; Barlow WE; Budd GT; Stram DO; Haiman CA; Sheng X; Yan L; Zirpoli G; Yao S; Jiang C; Owzar K; Hershman D; Albain KS; Hayes DF; Moore HC; Hobday TJ; Stewart JA; Rizvi A; Isaacs C; Salim M; Gralow JR; Hortobagyi GN; Livingston RB; Kroetz DL; Ambrosone CB
Pharmacogenet Genomics; 2018 Feb; 28(2):49-55. PubMed ID: 29278617
[TBL] [Abstract][Full Text] [Related]
6. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
[TBL] [Abstract][Full Text] [Related]
7. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
8. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
[TBL] [Abstract][Full Text] [Related]
9. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
[No Abstract] [Full Text] [Related]
10. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
[TBL] [Abstract][Full Text] [Related]
11. Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.
Laššuthová P; Vill K; Erdem-Ozdamar S; Schröder JM; Topaloglu H; Horvath R; Müller-Felber W; Bansagi B; Schlotter-Weigel B; Gläser D; Neupauerová J; Sedláčková L; Staněk D; Mazanec R; Weis J; Seeman P; Senderek J
Clin Genet; 2018 Nov; 94(5):467-472. PubMed ID: 30028002
[TBL] [Abstract][Full Text] [Related]
12. Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Tolaney SM; Guo H; Pernas S; Barry WT; Dillon DA; Ritterhouse L; Schneider BP; Shen F; Fuhrman K; Baltay M; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer B; Partridge AH; Hudis CA; Krop IE; Burstein HJ; Winer EP
J Clin Oncol; 2019 Aug; 37(22):1868-1875. PubMed ID: 30939096
[TBL] [Abstract][Full Text] [Related]
13. Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
Tanabe Y; Shiraishi S; Hashimoto K; Ikeda K; Nishizawa D; Hasegawa J; Shimomura A; Ozaki Y; Tamura N; Yunokawa M; Yonemori K; Takano T; Kawabata H; Tamura K; Fujiwara Y; Shimizu C
BMC Cancer; 2020 Apr; 20(1):325. PubMed ID: 32295642
[TBL] [Abstract][Full Text] [Related]
14. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
Boora GK; Kulkarni AA; Kanwar R; Beyerlein P; Qin R; Banck MS; Ruddy KJ; Pleticha J; Lynch CA; Behrens RJ; Züchner S; Loprinzi CL; Beutler AS
J Neurol Sci; 2015 Oct; 357(1-2):35-40. PubMed ID: 26143528
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.
Apellániz-Ruiz M; Lee MY; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; García-Estévez L; Sereno M; García-Donás J; Castelo B; Guerra E; Leandro-García LJ; Cascón A; Johansson I; Robledo M; Ingelman-Sundberg M; Rodríguez-Antona C
Clin Cancer Res; 2015 Jan; 21(2):322-8. PubMed ID: 25398452
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Baldwin RM; Owzar K; Zembutsu H; Chhibber A; Kubo M; Jiang C; Watson D; Eclov RJ; Mefford J; McLeod HL; Friedman PN; Hudis CA; Winer EP; Jorgenson EM; Witte JS; Shulman LN; Nakamura Y; Ratain MJ; Kroetz DL
Clin Cancer Res; 2012 Sep; 18(18):5099-109. PubMed ID: 22843789
[TBL] [Abstract][Full Text] [Related]
17. Targeted Sequencing Reveals Low-Frequency Variants in
Apellániz-Ruiz M; Tejero H; Inglada-Pérez L; Sánchez-Barroso L; Gutiérrez-Gutiérrez G; Calvo I; Castelo B; Redondo A; García-Donás J; Romero-Laorden N; Sereno M; Merino M; Currás-Freixes M; Montero-Conde C; Mancikova V; Åvall-Lundqvist E; Green H; Al-Shahrour F; Cascón A; Robledo M; Rodríguez-Antona C
Clin Cancer Res; 2017 Mar; 23(5):1227-1235. PubMed ID: 27582484
[No Abstract] [Full Text] [Related]
18. Charcot-Marie-Tooth 4B2 caused by a novel mutation in the MTMR13/SBF2 gene in two related Portuguese families.
Negrão L; Almendra L; Ribeiro J; Matos A; Geraldo A; Pinto-Basto J
Acta Myol; 2014 Dec; 33(3):144-8. PubMed ID: 25873783
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.
Senderek J; Bergmann C; Weber S; Ketelsen UP; Schorle H; Rudnik-Schöneborn S; Büttner R; Buchheim E; Zerres K
Hum Mol Genet; 2003 Feb; 12(3):349-56. PubMed ID: 12554688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]